Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opiranserin cream for myofascial pain syndrome
KCT0007704Phase 2Completed
- Sponsor
- Vivozon Pharmaceutical
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of opiranserin in chronic myofascial pain (CMP), sponsored by Vivozon Pharmaceutical. Started Jun 2022; status: completed.
02
Drugs
opiranserin
03
Conditions
chronic myofascial pain (CMP)
Beyond the preview
Go deeper on KCT0007704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007704.